Pathophysiology of HNPP explored using axonal excitability

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 7, 2013, Pages 806-812

  Jankelowitz, Stacey K ^a   Burke, David ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANATOMICAL VARIATION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; FEMALE; HEREDITARY LIABILITY TO PRESSURE PALSY; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; HYPERPOLARIZATION; LATENT PERIOD; MALE; MOTONEURON; NERVE BIOPSY; NERVE CELL EXCITABILITY; NEUROANATOMY; NEUROPATHOLOGY; PHENOTYPIC VARIATION; PRIORITY JOURNAL; RANVIER NODE; REPRODUCIBILITY; SENSITIVITY ANALYSIS;

EID: 84878765644     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-304576     Document Type: Article

References (39)

1. Silander K, Halonen P, Sara R, et al. DNA analysis in Finnish patients with hereditary neuropathy with liability to pressure palsies (HNPP). J Neurol Neurosurg Psychiatry 1994;57:1260-2. (Pubitemid 24321103)
2. Murakami T, Garcia RA, Reiter LT, et al. Charcot-Marie-Tooth disease and related inherited neuropathies. Medicine 1996;75:233-50. (Pubitemid 26337844)
3. Quarles RH. Myelin sheaths: glycoproteins involved in their formation, maintenance and degeneration. Cell Mol Life Sci 2002;59:1851-71. (Pubitemid 36015860)
4. Naef R, Suter U. Many facets of the peripheral myelin protein PMP22 in myelination and disease. Microsc Res Tech 1998;41:359-71. (Pubitemid 28308900)
5. Muller HW. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses. Glia 2000;29:182-5. (Pubitemid 30044513)
6. Gabreëls-Festen A, Wetering RV. Human nerve pathology caused by different mutational mechanisms of the PMP22 gene. Ann N Y Acad Sci 1999;883:336-43.
7. Mouton P, Tardieu S, Gouider R, et al. Spectrum of clinical and electrophysiological features in HNPP patients with the 17p11.2 deletion. Neurology 1999;52:1440-6. (Pubitemid 29190538)
8. Hong YH, Kim M, Kim HJ, et al. Clinical and electrophysiological features of HNPP patients with 17p11.2 deletion. Acta Neurol Scand 2003;108:352-8. (Pubitemid 37357640)
9. Gabreëls-Festen AA, Gabreëls FJ, Joosten EM, et al. Hereditary neuropathy with liability to pressure palsies in childhood. Neuropediatrics 1992;23:138-43.
10. Koike H, Hirayama M, Yamamoto M, et al. Age associated axonal features in HNPP with 17p11.2 deletion in Japan. J Neurol Neurosurg Psychiatry 2005;76:1109-14. (Pubitemid 41081286)
11. Kiernan MC, Hart IK, Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 2001;70:56-64. (Pubitemid 32096121)
12. Ng K, Kumar K, Brew B, et al. Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients. J Neurol Neurosurg Psychiatry 2011;82:978-80.
13. Kanai K, Shibuya K, Sato Y, et al. Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012;83:734-8.
14. Kaji R, Oka N, Tsuji T, et al. Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993;33:152-8. (Pubitemid 23039923)
15. Cappelen-Smith C, Kuwabara S, Lin CSY, et al. Activity-dependent hyperpolarization and conduction block in chronic inflammatory demyelinating polyneuropathy. Ann Neurol 2000;48:826-32.
16. Cappelen-Smith C, Kuwabra S, Lin CSY, et al. Membrane properties in chronic inflammatory demyelinating polyneuropathy. Brain 2001;124:2439-47. (Pubitemid 33134933)
17. Sung JY, Kuwabara S, Kaji R, et al. Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles. Muscle Nerve 2004;29:28-37. (Pubitemid 38040553)
18. Kaji R, Bostock H, Kohara N, et al. Activity-dependent conduction block in multifocal motor neuropathy. Brain 2000;123:1602-11. (Pubitemid 30481184)
19. Cappelen-Smith C, Kuwabara S, Lin CS, et al. Abnormalities of axonal excitability are not generalised in early multifocal motor neuropathy. Muscle Nerve 2002;26:769-76. (Pubitemid 35424426)
20. Kiernan MC, Guglielmi JM, Kaji R, et al. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain 2002;125:664-75. (Pubitemid 34194419)
21. Nodera H, Bostock H, Kuwabara S, et al. Nerve excitability properties in Charcot-Marie-Tooth disease type IA. Brain 2004;127:203-11. (Pubitemid 38055359)
22. Kiernan MC, Burke D, Andersen KV, et al. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000;23:399-409. (Pubitemid 30126986)
23. Jankelowitz SK, Burke D. Axonal excitability in the forearm: normal data and differences along the median nerve. Clin Neurophysiol 2009;120:167-73.
24. Nodera H, Kaji R. Nerve excitability testing and its clinical application to neuromuscular diseases. Clin Neurophysiol 2005;117:1902-16. (Pubitemid 44247879)
25. Trevillion L, Howells J, Burke D. Outwardly rectifying deflections in threshold electrotonus due to K+ conductances. J Physiol 2007;580:685-96. (Pubitemid 46564192)
26. Bostock H, Baker M, Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol 1991;441:537-57.
27. Bostock H. MEMFIT: a computer program to aid interpretation of multiple excitability measurements on human motor axons. Clin Neurophysiol 2006;117:S85.
28. h in human myelinated axons. J Physiol 2012;590:1625-40.
29. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol 1982;323:117-44. (Pubitemid 12180900)
30. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137-58. (Pubitemid 28079733)
31. Munsch T, Pape H-C. Modulation of the hyperpolarization-activated cation current of rat thalamic relay neurones by intracellular pH. J Physiol 1999;519:493-504. (Pubitemid 29430011)
32. Pian P, Bucchi A, Decostanzo A, et al. Modulation of cyclic nucleotide-regulated HCN channels by PIP(2) and receptors coupled to phospholipase C. Pflugers Arch 2007;455:125-45. (Pubitemid 47403988)
33. Bai Y, Zhang X, Katona I, et al. Conduction block in PMP22 deficiency. J Neurosci 2010;30:600-8.
34. Hartline DK, Colman DR. Rapid conduction and the evolution of giant axons and myelinated fibres. Curr Biol 2007;17:R29-35. (Pubitemid 46027580)
35. Mogyoros I, Kiernan MC, Burke D, et al. Excitability changes in human sensory and motor axons during hyperventilation and ischaemia. Brain 1997;120:317-25. (Pubitemid 27107664)
36. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human axons. Brain 2000;123:2542-51.
37. 2+ exchanger. J Neurosci 1992;12:430-9.
38. 2+ exchange in anoxic/ischaemic injury of CNS myelinated axons. Ann N Y Acad Sci 1996;779:366-78.
39. + pump dysfunction in diabetic neuropathy. Brain 2008;131:1209-16.